Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
10.1172/jci72434 169
Qazi A, Pal J, Maitah M, Fulciniti M, Pelluru D, Nanjappa P,
Arterial and venous thrombosis in systemic and monogenic vasculitis
BOTTOM LINE In people with type 2 diabetes, sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) agonists outperform dipeptidyl-peptidase-4 (DPP-4) inhibitors and long-acting insulins as monotherapy or combination therapy, reducing all-cause mortality, major cardiovascular events, chronic kidney disease, and heart failure
These numbers confirm very strong demand, but they do not imply that incretin prescribing is already widespread across Indias full physician base
Use the map below to explore the countries where we work
US$ 27.44
US$ 28.26
US$ 27.28
